DCP Capital

Thesis

Greater China-focused private equity investing in consumer, industrial tech, and healthcare leaders.

Stages

Growth

Sectors

ConsumerHealthcare/MedtechFood and BeverageIndustrialManufacturingInsurTechLife SciencesHardware+1

Current fund: DCP Capital Partners II · 2022 · $$2.5B (first close; $3B target)
AUM: $$5B+

Israeli medical-device innovation house that invents, patents, and builds proprietary medtech startups.…

Growth-stage investor backing category-leading cannabis and cannabis-adjacent companies navigating evolving regulation.…

AI and robotics applied to transform foundational industries vertical by vertical.…